Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jarrett J Adams

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Nature Immunology|November 3, 2015
Structural interplay between germline interactions and adaptive recognition determines the bandwidth of TCR-peptide-MHC cross-reactivityJarrett J Adams, Samanthi Narayanan, Michael E Birnbaum, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2018
Highly multiplexed and quantitative cell-surface protein profiling using genetically barcoded antibodiesSamuel B Pollock, Amy Hu, Yun Mou, et al.
Immunity|November 22, 2011
T cell receptor signaling is limited by docking geometry to peptide-major histocompatibility complexJarrett J Adams, Samanthi Narayanan, Baoyu Liu, et al.
EMBO Molecular Medicine|June 9, 2021
A Norrin/Wnt surrogate antibody stimulates endothelial cell barrier function and rescues retinopathyRony Chidiac, Md Abedin, Graham Macleod, et al.
Journal of Molecular Biology|June 6, 2021
Inhibition of Cancer Cell Adhesion, Migration and Proliferation by a Bispecific Antibody that Targets two Distinct Epitopes on αv IntegrinsEugenio Gallo, Abdellali Kelil, Michael Haughey, et al.
Science Translational Medicine|November 20, 2024
Monoclonal antibodies that block Roundabout 1 and 2 signaling target pathological ocular neovascularization through myeloid cellsLuiz Henrique Geraldo, Yunling Xu, Gaspard Mouthon, et al.
Protein Science : a Publication of the Protein Society|May 25, 2026
Dual targeting of inhibitory EGFR epitopes with synthetic antibodies in therapeutic-resistant cancersJarrett J Adams, Evan Mallette, Max London, et al.
Protein Science : a Publication of the Protein Society|September 17, 2025
An asymmetric tetrabody is a potent and efficacious agonist of the erythropoietin receptor in vitro and in vivoJarrett J Adams, Levi L Blazer, Jacky Chung, et al.
Protein Science : a Publication of the Protein Society|November 9, 2023
Engineered antigen-binding fragments for enhanced crystallization of antibody:antigen complexesHeather A Bruce, Alexander U Singer, Ekaterina V Filippova, et al.
Protein Science : a Publication of the Protein Society|January 20, 2026
Tetravalent antibodies are more potent and efficacious erythropoiesis-stimulating agents than erythropoietin in vivoJarrett J Adams, Levi L Blazer, Jacky Chung, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Nature Immunology|November 3, 2015
Structural interplay between germline interactions and adaptive recognition determines the bandwidth of TCR-peptide-MHC cross-reactivityJarrett J Adams, Samanthi Narayanan, Michael E Birnbaum, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2018
Highly multiplexed and quantitative cell-surface protein profiling using genetically barcoded antibodiesSamuel B Pollock, Amy Hu, Yun Mou, et al.
Immunity|November 22, 2011
T cell receptor signaling is limited by docking geometry to peptide-major histocompatibility complexJarrett J Adams, Samanthi Narayanan, Baoyu Liu, et al.
EMBO Molecular Medicine|June 9, 2021
A Norrin/Wnt surrogate antibody stimulates endothelial cell barrier function and rescues retinopathyRony Chidiac, Md Abedin, Graham Macleod, et al.
Journal of Molecular Biology|June 6, 2021
Inhibition of Cancer Cell Adhesion, Migration and Proliferation by a Bispecific Antibody that Targets two Distinct Epitopes on αv IntegrinsEugenio Gallo, Abdellali Kelil, Michael Haughey, et al.
Science Translational Medicine|November 20, 2024
Monoclonal antibodies that block Roundabout 1 and 2 signaling target pathological ocular neovascularization through myeloid cellsLuiz Henrique Geraldo, Yunling Xu, Gaspard Mouthon, et al.
Protein Science : a Publication of the Protein Society|May 25, 2026
Dual targeting of inhibitory EGFR epitopes with synthetic antibodies in therapeutic-resistant cancersJarrett J Adams, Evan Mallette, Max London, et al.
Protein Science : a Publication of the Protein Society|September 17, 2025
An asymmetric tetrabody is a potent and efficacious agonist of the erythropoietin receptor in vitro and in vivoJarrett J Adams, Levi L Blazer, Jacky Chung, et al.
Protein Science : a Publication of the Protein Society|November 9, 2023
Engineered antigen-binding fragments for enhanced crystallization of antibody:antigen complexesHeather A Bruce, Alexander U Singer, Ekaterina V Filippova, et al.
Protein Science : a Publication of the Protein Society|January 20, 2026
Tetravalent antibodies are more potent and efficacious erythropoiesis-stimulating agents than erythropoietin in vivoJarrett J Adams, Levi L Blazer, Jacky Chung, et al.
Pageof 5